117 related articles for article (PubMed ID: 15698944)
1. Cellular proteolysis and systemic inflammation during exacerbation in cystic fibrosis.
Ionescu AA; Nixon LS; Shale DJ
J Cyst Fibros; 2004 Dec; 3(4):253-8. PubMed ID: 15698944
[TBL] [Abstract][Full Text] [Related]
2. Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD.
Bolton CE; Broekhuizen R; Ionescu AA; Nixon LS; Wouters EF; Shale DJ; Schols AM
Thorax; 2007 Feb; 62(2):109-14. PubMed ID: 16928709
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary function, body composition, and protein catabolism in adults with cystic fibrosis.
Ionescu AA; Nixon LS; Luzio S; Lewis-Jenkins V; Evans WD; Stone MD; Owens DR; Routledge PA; Shale DJ
Am J Respir Crit Care Med; 2002 Feb; 165(4):495-500. PubMed ID: 11850342
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
[TBL] [Abstract][Full Text] [Related]
5. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
Hansen CR; Pressler T; Koch C; Høiby N
J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
[TBL] [Abstract][Full Text] [Related]
6. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
[TBL] [Abstract][Full Text] [Related]
7. Bone density, body composition, and inflammatory status in cystic fibrosis.
Ionescu AA; Nixon LS; Evans WD; Stone MD; Lewis-Jenkins V; Chatham K; Shale DJ
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):789-94. PubMed ID: 10988084
[TBL] [Abstract][Full Text] [Related]
8. The influence of body composition on respiratory muscle, lung function and diaphragm thickness in adults with cystic fibrosis.
Enright S; Chatham K; Ionescu AA; Unnithan VB; Shale DJ
J Cyst Fibros; 2007 Nov; 6(6):384-90. PubMed ID: 17400035
[TBL] [Abstract][Full Text] [Related]
9. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
10. Body composition assessment in adults with cystic fibrosis: comparison of dual-energy X-ray absorptiometry with skinfolds and bioelectrical impedance analysis.
King S; Wilson J; Kotsimbos T; Bailey M; Nyulasi I
Nutrition; 2005; 21(11-12):1087-94. PubMed ID: 16183254
[TBL] [Abstract][Full Text] [Related]
11. Cytokine pattern in cystic fibrosis patients during antibiotic therapy and gene therapy using adenoviral vector.
Reix P; Bellon G; Bienvenu J; Pavirani A; Levrey-Hadden H
Eur Cytokine Netw; 2002; 13(3):324-30. PubMed ID: 12231476
[TBL] [Abstract][Full Text] [Related]
12. Loss of fat-free mass over four years in adult cystic fibrosis is associated with high serum interleukin-6 levels but not tumour necrosis factor-alpha.
King SJ; Nyulasi IB; Bailey M; Kotsimbos T; Wilson JW
Clin Nutr; 2014 Feb; 33(1):150-5. PubMed ID: 23664115
[TBL] [Abstract][Full Text] [Related]
13. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
Bradbury R; Champion A; Reid DW
Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
[TBL] [Abstract][Full Text] [Related]
14. Effect of systemic inflammation on inspiratory and limb muscle strength and bulk in cystic fibrosis.
Dufresne V; Knoop C; Van Muylem A; Malfroot A; Lamotte M; Opdekamp C; Deboeck G; Cassart M; Stallenberg B; Casimir G; Duchateau J; Estenne M
Am J Respir Crit Care Med; 2009 Jul; 180(2):153-8. PubMed ID: 19342416
[TBL] [Abstract][Full Text] [Related]
15. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
Steinkamp G; Schmitt-Grohe S; Döring G; Staab D; Pfründer D; Beck G; Schubert R; Zielen S
Respir Med; 2008 Nov; 102(11):1643-53. PubMed ID: 18701270
[TBL] [Abstract][Full Text] [Related]
16. Association of body composition and lung function in children with cystic fibrosis.
Pedreira CC; Robert RG; Dalton V; Oliver MR; Carlin JB; Robinson P; Cameron FJ
Pediatr Pulmonol; 2005 Mar; 39(3):276-80. PubMed ID: 15668934
[TBL] [Abstract][Full Text] [Related]
17. Fat-free mass depletion in cystic fibrosis: associated with lung disease severity but poorly detected by body mass index.
King SJ; Nyulasi IB; Strauss BJ; Kotsimbos T; Bailey M; Wilson JW
Nutrition; 2010; 26(7-8):753-9. PubMed ID: 19931415
[TBL] [Abstract][Full Text] [Related]
18. Body composition and pulmonary function in the elderly: a 7-year longitudinal study.
Rossi A; Fantin F; Di Francesco V; Guariento S; Giuliano K; Fontana G; Micciolo R; Solerte SB; Bosello O; Zamboni M
Int J Obes (Lond); 2008 Sep; 32(9):1423-30. PubMed ID: 18645577
[TBL] [Abstract][Full Text] [Related]
19. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
Groenewegen KH; Dentener MA; Wouters EF
Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
